Published in J Urol on May 14, 2014
An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma. J Urol (2003) 3.21
Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence. Pharmacol Rev (2004) 3.08
The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study. BJU Int (2009) 2.63
Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging. Urology (2006) 2.59
Urinary retention and post-void residual urine in men: separating truth from tradition. J Urol (2008) 2.57
Minimal tumor volume may provide additional prognostic information in good performance patients after radical prostatectomy. Urology (2007) 2.09
The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS. BJU Int (2009) 2.00
Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. Br J Pharmacol (2006) 1.94
Global prevalence and economic burden of urgency urinary incontinence: a systematic review. Eur Urol (2013) 1.83
Repeat prostate biopsy and the incremental risk of clinically insignificant prostate cancer. Urology (2011) 1.70
Preoperative parameters, including percent positive biopsy, in predicting seminal vesicle involvement in patients with prostate cancer. J Urol (2006) 1.64
Lower urinary tract symptoms revisited: a broader clinical perspective. Eur Urol (2008) 1.62
Nocturia Think Tank: focus on nocturnal polyuria: ICI-RS 2011. Neurourol Urodyn (2012) 1.56
Downregulation of cGMP-dependent protein kinase-1 activity in the corpus cavernosum smooth muscle of diabetic rabbits. Am J Physiol Regul Integr Comp Physiol (2004) 1.55
A randomized controlled trial of intravesical bacillus calmette-guerin for treatment refractory interstitial cystitis. J Urol (2005) 1.54
Impact on renal function of percutaneous thermal ablation of renal masses in patients with preexisting chronic kidney disease. J Vasc Interv Radiol (2011) 1.54
The New England Research Institutes, Inc. (NERI) Nocturia Advisory Conference 2012: focus on outcomes of therapy. BJU Int (2013) 1.52
Urodynamic studies in adults: AUA/SUFU guideline. J Urol (2012) 1.51
Identification of clinically significant prostate cancer by prostate-specific antigen screening. Arch Intern Med (2004) 1.46
Enucleation of renal cell carcinoma with ablation of the tumour base. BJU Int (2008) 1.41
The overlap of storage, voiding and postmicturition symptoms and implications for treatment seeking in the USA, UK and Sweden: EpiLUTS. BJU Int (2009) 1.40
Association between utility and treatment among patients with prostate cancer. Qual Life Res (2010) 1.39
Obstruction-induced changes in urinary bladder smooth muscle contractility: a role for Rho kinase. Am J Physiol Renal Physiol (2003) 1.27
Detrusor overactivity is associated with downregulation of large-conductance calcium- and voltage-activated potassium channel protein. Am J Physiol Renal Physiol (2010) 1.21
CYP3A4, CYP3A5, and CYP3A43 genotypes and haplotypes in the etiology and severity of prostate cancer. Cancer Res (2004) 1.21
Pharmacological treatment of overactive bladder: report from the International Consultation on Incontinence. Curr Opin Urol (2009) 1.19
Increased basal phosphorylation of detrusor smooth muscle myosin in alloxan-induced diabetic rabbit is mediated by upregulation of Rho-kinase beta and CPI-17. Am J Physiol Renal Physiol (2005) 1.12
Diabetes induced decrease in detrusor smooth muscle force is associated with oxidative stress and overactivity of aldose reductase. J Urol (2005) 1.12
Endorectal T2-weighted MRI does not differentiate between favorable and adverse pathologic features in men with prostate cancer who would qualify for active surveillance. Urol Oncol (2012) 1.12
Benign prostatic hyperplasia in primary care: what you need to know. J Urol (2006) 1.08
Experimental colitis triggers the release of substance P and calcitonin gene-related peptide in the urinary bladder via TRPV1 signaling pathways. Exp Neurol (2010) 1.07
Diagnosis and reconstruction of the dorsal or circumferential urethral diverticulum. J Urol (2003) 1.07
Alteration in expression of myosin isoforms in detrusor smooth muscle following bladder outlet obstruction. Am J Physiol Cell Physiol (2003) 1.06
Ethnic variation in return to baseline values of patient-reported outcomes in older prostate cancer patients. Cancer (2007) 1.04
Are urodynamic tests useful tools for the initial conservative management of non-neurogenic urinary incontinence? A review of the literature. Eur Urol (2003) 1.03
Alteration of the PKC-mediated signaling pathway for smooth muscle contraction in obstruction-induced hypertrophy of the urinary bladder. Lab Invest (2009) 1.02
Stress incontinence injection therapy: what is best for our patients? Eur Urol (2005) 1.00
Embolization of giant renal angiomyolipomas: technique and results. J Vasc Interv Radiol (2010) 0.99
Health-related quality of life and satisfaction with care among older men treated for prostate cancer with either radical prostatectomy or external beam radiation therapy. BJU Int (2006) 0.99
Satisfaction with care: a measure of quality of care in prostate cancer patients. Med Decis Making (2009) 0.97
The evaluation and treatment of nocturia: a consensus statement. BJU Int (2011) 0.97
Smooth muscle hypertrophy following partial bladder outlet obstruction is associated with overexpression of non-muscle caldesmon. Am J Pathol (2004) 0.96
Once-daily, extended-release formulations of antimuscarinic agents in the treatment of overactive bladder: a review. Eur Urol (2002) 0.95
Treatment options for stress urinary incontinence. Rev Urol (2004) 0.95
Urinary incontinence: pharmacotherapy options. Ann Med (2011) 0.94
Alterations in caveolin expression and ultrastructure after bladder smooth muscle hypertrophy. J Urol (2009) 0.94
The bladder-brain connection: putative role of corticotropin-releasing factor. Nat Rev Urol (2010) 0.92
Joint effects of inflammation and androgen metabolism on prostate cancer severity. Int J Cancer (2008) 0.90
Comparison of prostate volume measured by transrectal ultrasound and magnetic resonance imaging: is transrectal ultrasound suitable to determine which patients should undergo active surveillance? Urol Oncol (2012) 0.89
Outcomes of pharmacological management of nocturia with non-antidiuretic agents: does statistically significant equal clinically significant? BJU Int (2011) 0.88
Spontaneous and evoked contractions are regulated by PKC-mediated signaling in detrusor smooth muscle: involvement of BK channels. Am J Physiol Renal Physiol (2012) 0.88
Comparison of distribution- and anchor-based approaches to infer changes in health-related quality of life of prostate cancer survivors. Health Serv Res (2012) 0.88
The burden of out-of-pocket and indirect costs of prostate cancer. Prostate (2010) 0.88
Incidence and prevalence of overactive bladder. Curr Urol Rep (2002) 0.87
The Kallikrein Panel for prostate cancer screening: its economic impact. Prostate (2013) 0.87
Regional differences in myosin heavy chain isoform expression and maximal shortening velocity of the rat vaginal wall smooth muscle. Am J Physiol Regul Integr Comp Physiol (2006) 0.86
Functional significance of muscarinic receptor expression within the proximal and distal rat vagina. Am J Physiol Regul Integr Comp Physiol (2009) 0.86
Neuroendocrine tumor of the bladder. Rev Urol (2010) 0.86
GATA-6 and NF-κB activate CPI-17 gene transcription and regulate Ca2+ sensitization of smooth muscle contraction. Mol Cell Biol (2012) 0.86
Increased corpus cavernosum smooth muscle tone associated with partial bladder outlet obstruction is mediated via Rho-kinase. Am J Physiol Regul Integr Comp Physiol (2005) 0.85
Altered expression of thin filament-associated proteins in hypertrophied urinary bladder smooth muscle. Neurourol Urodyn (2006) 0.85
A case of synchronous bilateral testicular seminoma. Nat Clin Pract Urol (2008) 0.85
Transcriptional repression of Caveolin-1 (CAV1) gene expression by GATA-6 in bladder smooth muscle hypertrophy in mice and human beings. Am J Pathol (2011) 0.85
Urological symptom clusters and health-related quality-of-life: results from the Boston Area Community Health Survey. BJU Int (2009) 0.85
Acute colonic inflammation triggers detrusor instability via activation of TRPV1 receptors in a rat model of pelvic organ cross-sensitization. Am J Physiol Regul Integr Comp Physiol (2011) 0.84
A critical review of diagnostic criteria for evaluating patients with symptomatic stress urinary incontinence. BJU Int (2005) 0.84
Deletion of SM-B, the high ATPase isoform of myosin, upregulates the PKC-mediated signal transduction pathway in murine urinary bladder smooth muscle. Am J Physiol Renal Physiol (2008) 0.84
Over expression of smooth muscle thin filament associated proteins in the bladder wall of diabetics. J Urol (2005) 0.83
Contractile response of human anterior vaginal muscularis in women with and without pelvic organ prolapse. Reprod Sci (2010) 0.83
Re: An International Urogynecological Association (IUGA)/International Continence Society (ICS) Joint Report on the Terminology for Female Pelvic Floor Dysfunction. J Urol (2011) 0.83
Regional alterations in the expression of smooth muscle myosin isoforms in response to partial bladder outlet obstruction. J Urol (2005) 0.83
How dry is "OAB-dry"? Perspectives from patients and physician experts. J Urol (2012) 0.81
Nocturia: new directions. Neurourol Urodyn (2011) 0.81
Evaluation of lower urinary tract symptoms in females. Curr Opin Urol (2003) 0.81
Hydronephrosis is an independent predictor of poor clinical outcome in patients treated for muscle-invasive transitional cell carcinoma with radical cystectomy. Urology (2008) 0.80
Comparison of radiographical imaging modalities for measuring the diameter of renal masses: is there a sizeable difference? BJU Int (2011) 0.80
Anthropometric differences in obese men with biochemical failure after radical retropubic prostatectomy. Urol Oncol (2011) 0.79
Racial differences in well-being and cancer concerns in prostate cancer patients. J Cancer Surviv (2011) 0.79
Predictors of patient reported outcomes and cost of care in younger men with newly diagnosed prostate cancer. Prostate (2009) 0.79
Enhanced force generation by corpus cavernosum smooth muscle in rabbits with partial bladder outlet obstruction. J Urol (2002) 0.79
Detrusor overactivity leak point pressure in women with urgency incontinence. Int Urogynecol J (2011) 0.78
Estrogen replacement therapy for the treatment of postmenopausal genitourinary tract dysfunction. Discov Med (2010) 0.78
Effect of the Bowman-Birk inhibitor (a soy protein) on in vitro bladder neck/urethral and penile corporal smooth muscle activity. Neurourol Urodyn (2003) 0.78
An appraisal of the Food and Drug Administration warning on urogynecologic surgical mesh. Curr Urol Rep (2012) 0.78
Generation of a cell line with smooth muscle phenotype from hypertrophied urinary bladder. Am J Physiol Cell Physiol (2002) 0.78
Defining pathological variables to predict biochemical failure in patients with positive surgical margins at radical prostatectomy: implications for adjuvant radiotherapy. BJU Int (2009) 0.78
Health related quality of life and direct medical care cost in newly diagnosed younger men with prostate cancer. J Urol (2005) 0.78
Percutaneous computed tomography-guided renal mass radiofrequency ablation versus cryoablation: doses of sedation medication used. J Vasc Interv Radiol (2013) 0.78
Re: SUI surgery at the time of vaginal POP repair: is a surgical algorithm possible or desirable? J Urol (2012) 0.78
Re: TRP Channels in Lower Urinary Tract Dysfunction. J Urol (2015) 0.77
The clinical and pathological history of prostate cancer progression in men with a prior history of high grade prostatic intraepithelial neoplasia. Can J Urol (2008) 0.77
Effect of estrogen on molecular and functional characteristics of the rodent vaginal muscularis. J Sex Med (2013) 0.77
Decrease in maximal force generation in the neonatal mouse bladder corresponds to shift in myosin heavy chain isoform composition. J Urol (2004) 0.77
Urologic complications of nonurologic medications. Urol Clin North Am (2003) 0.77
Update on overactive bladder: pharmacologic approaches on the horizon. Curr Urol Rep (2003) 0.77
Partial bladder outlet obstruction induces urethral smooth muscle hypertrophy and decreased force generation. J Urol (2006) 0.77
Defining and managing overactive bladder: disagreement among the experts. Urology (2013) 0.77
Evaluation and treatment of the overactive bladder. Rev Hosp Clin Fac Med Sao Paulo (2002) 0.77